See also this year's filing and all EDGAR filings for this company.
PDF Report 0001124105_2022_GYRE_Therapeutics_INC.pdf
Logs
Graph
Absolute values for 0001124105, GYRE Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 51,476,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 970,000 |
| 3 | remainder_Assets | 3,216,000 |
| 4 | LiabilitiesCurrent | 14,165,000 |
| 5 | LiabilitiesNoncurrent | 408,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 19,546,238 |
| 9 | ResearchAndDevelopmentExpense | 65,837,207 |
| 10 | remainder_Expenses | 7,861,966 |
| 11 | remainder_Revenues | 8,861,832 |
| 12 | remainder_NetIncome | 292,880 |
| 13 | remainder_ComprehensiveNetIncome | -12,947 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 55,662,000 |
| 1 | Liabilities | 14,573,000 |
| 2 | Expenses | 93,245,411 |
| 3 | Revenues | 8,861,832 |
| 4 | StockholdersEquity | 41,089,000 |
| 5 | NetIncome | -84,090,699 |
| 6 | ComprehensiveNetIncome | -84,097,172 |
| 7 | BaseVar | 86,324,035 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.156 |
| 9 | EconomicCapitalRatio | 1.56 |
Edgar->Model Mapping
Feature Distribution
Change over Time
